Board

Fredrik Olsson
Chairman of the Board since 2026
Fredrik Olsson, born in 1962, is an entrepreneur and investor with a special interest in growth companies in the Life Science sector. Fredrik has extensive experience of board work in listed companies, corporate governance and ownership-related issues. Fredrik Olsson is a member of the board of directors of Enorama Pharma AB (publ) and chairman of the company’s nomination committee. Fredrik is also a board member of ASA des Palus de St Germain de la Rivière and CEO of Château Baulos la Rivière SAS.
Holdings in Intellego: –
Independence in relation to the company and its management: Yes
Independence in relation to the company’s major shareholders: Yes

Mats Geijer
Board Member since 2026
Mats Geijer, born 1977, is a legal professional with 25 years of experience with background in shipping, insurance and litigation. Mats possesses special expertise in legal and regulatory challenges in connection with companies in turnaround, special-sits and disputes. Mats is also a board member of Aktiebolaget Fastator (publ), Park Capital AB and is currently Head of Nordics at Deminor Litigation Funding. Mats has published several articles related to publicly listed companies in disputes and is often engaged as speaker at conferences on this topic.
Holdings in Intellego: –
Independence in relation to the company and its management: Yes
Independence in relation to the company’s major shareholders: Yes

David Pastrana
Board Member since 2026
David Pastrana, born in 1976, MBA from INSEAD, has more than 15 years of experience as President and CEO, and was previously CEO of Inditex USA. David is currently Managing Partner of Founders Capital, a differentiated Private Equity Firm, and a member of the board of directors of TSM. David has solid international leadership experience from large, complex organizations with a strong commercial focus and a proven ability to drive structured growth, operational efficiency and change management.
Holdings in Intellego: 139,261 shares
Independence in relation to the company and its management: Yes
Independence in relation to the company’s major shareholders: Yes